WallStSmart

MKS Instruments Inc (MKSI)vsUSBC, Inc. (USBC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MKSI leads profitability with a 7.5% profit margin vs 0.0%. MKSI earns a higher WallStSmart Score of 55/100 (C-).

MKSI

Buy

55

out of 100

Grade: C-

Growth: 6.0Profit: 5.5Value: 4.7Quality: 7.0
Piotroski: 5/9Altman Z: 1.20

USBC

Avoid

23

out of 100

Grade: F

Growth: 4.3Profit: 3.0Value: 5.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MKSISignificantly Overvalued (-64.0%)

Margin of Safety

-64.0%

Fair Value

$158.01

Current Price

$243.68

$85.67 premium

UndervaluedFair: $158.01Overvalued

Intrinsic value data unavailable for USBC.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MKSI0 strengths · Avg: 0/10

No standout strengths identified

USBC1 strengths · Avg: 10.0/10
Price/BookValuation
1.4x10/10

Reasonable price relative to book value

Areas to Watch

MKSI4 concerns · Avg: 2.5/10
Profit MarginProfitability
7.5%3/10

7.5% margin — thin

Debt/EquityHealth
1.763/10

Elevated debt levels

P/E RatioValuation
55.9x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

USBC4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$136.94M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : MKSI

Revenue growth of 10.6% demonstrates continued momentum. PEG of 1.32 suggests the stock is reasonably priced for its growth.

Bull Case : USBC

The strongest argument for USBC centers on Price/Book.

Bear Case : MKSI

The primary concerns for MKSI are Profit Margin, Debt/Equity, P/E Ratio. A P/E of 55.9x leaves little room for execution misses. Debt-to-equity of 1.76 is elevated, increasing financial risk.

Bear Case : USBC

The primary concerns for USBC are Revenue Growth, EPS Growth, Market Cap.

Key Dynamics to Monitor

MKSI carries more volatility with a beta of 1.92 — expect wider price swings.

MKSI is growing revenue faster at 10.6% — sustainability is the question.

MKSI generates stronger free cash flow (91M), providing more financial flexibility.

Monitor SCIENTIFIC & TECHNICAL INSTRUMENTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MKSI scores higher overall (55/100 vs 23/100) and 10.6% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

MKS Instruments Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

MKS Instruments, Inc. provides instruments, systems, subsystems, and process control solutions that measure, monitor, deliver, analyze, power, and control critical parameters of manufacturing processes globally. The company is headquartered in Andover, Massachusetts.

Visit Website →

USBC, Inc.

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

US BioTec, Inc. engages in the development, manufacture, marketing, and distribution of bio-degradable, nontoxic, and noncarcinogenic products in the United States. The company is headquartered in Gleason, Tennessee.

Want to dig deeper into these stocks?